109 related articles for article (PubMed ID: 25117075)
1. Polymorphism in interleukin 21 gene is associated with decreased susceptibility to diffuse large B cell lymphoma.
Li J; Mai J
Tumour Biol; 2014 Nov; 35(11):11295-300. PubMed ID: 25117075
[TBL] [Abstract][Full Text] [Related]
2. Functional interleukin-21 polymorphism is a protective factor of diffuse large B-cell lymphoma.
Wang H; Wang M; Feng Z; Chen L; Gao L; Li Q; Zhang L; Ma J
DNA Cell Biol; 2014 Nov; 33(11):775-80. PubMed ID: 25126827
[TBL] [Abstract][Full Text] [Related]
3. Association of ERCC2 Gene Polymorphisms with Susceptibility to Diffuse Large B-Cell Lymphoma.
Tong Y; Xiang Y; Li B; Bao S; Zhou Y; Yuan W; Ling Y; Hao D; Zhu H; Sun Z
Med Sci Monit; 2018 Oct; 24():7015-7022. PubMed ID: 30279407
[TBL] [Abstract][Full Text] [Related]
4. Genetic association of interleukin-10 promoter polymorphisms and susceptibility to diffuse large B-cell lymphoma: a meta-analysis.
Cao HY; Zou P; Zhou H
Gene; 2013 May; 519(2):288-94. PubMed ID: 23485354
[TBL] [Abstract][Full Text] [Related]
5. Influence of polymorphisms in genes encoding immunoregulatory proteins and metabolizing enzymes on susceptibility and outcome in patients with diffuse large B-cell lymphoma treated with rituximab.
Yri OE; Ekstrøm PO; Hilden V; Gaudernack G; Liestøl K; Smeland EB; Holte H
Leuk Lymphoma; 2013 Oct; 54(10):2205-14. PubMed ID: 23391141
[TBL] [Abstract][Full Text] [Related]
6. LTA, LEP, and TNF-a Gene Polymorphisms are Associated with Susceptibility and Overall Survival of Diffuse Large B-Cell lymphoma in an Arab Population: A Case-Control Study.
Al-Khatib SM; Abdo N; Al-Eitan LN; Al-Mistarehi AW; Zahran DJ; Kewan TZ
Asian Pac J Cancer Prev; 2020 Sep; 21(9):2783-2791. PubMed ID: 32986381
[TBL] [Abstract][Full Text] [Related]
7. CD38 and interleukin 6 gene polymorphism in egyptians with diffuse large B-cell lymphoma (DLBCL).
Talaat RM; Abdel-Aziz AM; El-Maadawy EA; Abdel-Bary N
Immunol Invest; 2015; 44(3):265-78. PubMed ID: 25564959
[TBL] [Abstract][Full Text] [Related]
8. Excision repair cross-complementing group 2/Xeroderma pigmentousm complementation group D (ERCC2/XPD) genetic variations and susceptibility to diffuse large B cell lymphoma in Egypt.
El-Din MA; Khorshied MM; El-Saadany ZA; El-Banna MA; Reda Khorshid OM
Int J Hematol; 2013 Dec; 98(6):681-6. PubMed ID: 24258710
[TBL] [Abstract][Full Text] [Related]
9. Association of interleukin-10, tumor necrosis factor-α and transforming growth factor-β gene polymorphisms with the outcome of diffuse large B-cell lymphomas.
Tarabar O; Cikota-Aleksić B; Tukić L; Milanović N; Aleksić A; Magić Z
Int J Clin Oncol; 2014 Feb; 19(1):186-92. PubMed ID: 23532628
[TBL] [Abstract][Full Text] [Related]
10. Association of MNS16A VNTR and hTERT rs2736098: G>A polymorphisms with susceptibility to diffuse large B-cell lymphoma.
Essa ES; Alagizy HA
Tumori; 2018 Jun; 104(3):165-171. PubMed ID: 28967095
[TBL] [Abstract][Full Text] [Related]
11. BCRP gene polymorphisms are associated with susceptibility and survival of diffuse large B-cell lymphoma.
Hu LL; Wang XX; Chen X; Chang J; Li C; Zhang Y; Yang J; Jiang W; Zhuang SM
Carcinogenesis; 2007 Aug; 28(8):1740-4. PubMed ID: 17494054
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 27 -964A > G genetic polymorphism and serum IL-27p28 levels in Chinese patients with papillary thyroid cancer.
Zhang S; Gao X; Wang Y; Jia J; Zhang Q; Ji Z
Tumour Biol; 2015 Sep; 36(10):8207-11. PubMed ID: 25994572
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma.
Lech-Maranda E; Baseggio L; Bienvenu J; Charlot C; Berger F; Rigal D; Warzocha K; Coiffier B; Salles G
Blood; 2004 May; 103(9):3529-34. PubMed ID: 14701701
[TBL] [Abstract][Full Text] [Related]
14. Association of interleukin-27 gene polymorphisms with susceptibility to HIV infection and disease progression.
Pang XX; Luo SD; Zhang T; Shi F; Wang CF; Chen XH; Wei YX; Qin L; Wei JX; Luo XQ; Wang JL
J Cell Mol Med; 2019 Apr; 23(4):2410-2418. PubMed ID: 30632263
[TBL] [Abstract][Full Text] [Related]
15. [Gene Polymorphism of Inflammation-related Cytokines Correlates with the Susceptibility to DLBCL].
Tian CP; Liao SQ; Yuan HX; Yao BC; Wang F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):444-448. PubMed ID: 28446290
[TBL] [Abstract][Full Text] [Related]
16. Association between matrix metalloproteinase 2 (MMP2) promoter polymorphisms and the susceptibility to non-Hodgkin's lymphoma in Egyptians.
Gouda HM; Khorshied MM; El Sissy MH; Shaheen IA; Mohsen MM
Ann Hematol; 2014 Aug; 93(8):1313-8. PubMed ID: 24627195
[TBL] [Abstract][Full Text] [Related]
17. Genetic variations in interleukin-6 polymorphism and the association with susceptibility and overall survival of osteosarcoma.
Qi Y; Zhao C; Li H; Zhang B; Tada K; Abe H; Tada M
Tumour Biol; 2016 Jul; 37(7):9807-11. PubMed ID: 26810186
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-21 polymorphism affects gene expression and is associated with risk of ischemic stroke.
Li G; Xu R; Cao Y; Xie X; Zheng Z
Inflammation; 2014 Dec; 37(6):2030-9. PubMed ID: 24879484
[TBL] [Abstract][Full Text] [Related]
19. MDR1 polymorphisms associated with risk and survival in diffuse large B-cell lymphoma.
Hu LL; Yu B; Yang J
Leuk Lymphoma; 2013 Jun; 54(6):1188-93. PubMed ID: 23088763
[TBL] [Abstract][Full Text] [Related]
20. Association of interleukin-22 polymorphisms with the colon cancer: A case-control study.
Lin L; Xu W; Zhang G; Ren P; Zhao J; Yan Q
Immunol Lett; 2017 Aug; 188():59-63. PubMed ID: 28624523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
